Lupus (SLE) trials in Austria

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

  Where

  Graz, Linz, Vienna

  Age

  5 years to 80 years

  People

  1,072 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07691970
• Phase 3Not yet taking people in Austria
  Rollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.

  Where

  Graz, Linz, Vienna

  People

  340 worldwide

  Run by

  AstraZeneca AB

  See details and how to join2026-526419-13-00 · EU 2026-526419-13-00
• Phase 1Not yet taking people in Austria
  A study to learn how dapirolizumab pegol transfers to babies from pregnant mothers with active systemic lupus erythematosus

  Where

  Vienna

  Age

  Up to 64 years

  People

  10 worldwide

  Run by

  UCB Biopharma

  See details and how to join2025-524595-37-00 · EU 2025-524595-37-00